Ma, Jun. 2025. “1 Clinical Efficacy and Serum Inflammatory Factor Level (serum IFCs, Bone Gla Protein (BGP), and Bone Turnover Markers β-Collagen Degradation Product (β-CTX), and Procollagen Type 1 N-Terminal Propeptide (P1NP) )Changes of Zoledronic Acid and Denosumab in T: Serum IFCs, Bone Gla Protein (BGP), and Bone Turnover Markers β-Collagen Degradation Product (β-CTX), and Procollagen Type 1 N-Terminal Propeptide (P1NP) )”. Journal of Medical Biochemistry 44 (3): 587-94. https://doi.org/10.5937/jomb0-51444.